Antifungal, cytotoxic activities and docking studies of 2,5-dimercapto-1,3,4-thiadiazole derivatives

被引:9
作者
Samee, Weerasak [1 ]
Vajragupta, Opa [2 ]
机构
[1] Srinakharinwirot Univ, Fac Pharm, Dept Pharmaceut Chem & Pharmacognosy, Nakhon Nayok, Thailand
[2] Mahidol Univ, Fac Pharm, Dept Pharmaceut Chem, Bangkok 10700, Thailand
关键词
2,5-dimercapto-1,3,4-thiadiazol; docking; cytotoxicity; antifungal; IN-VITRO; AZOLE RESISTANCE; 1,3,4-THIADIAZOLES; INFECTIONS; DESIGN; CYP51;
D O I
10.5897/AJPP10.156
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A series of 2,5-dimercapto-1,3,4-thiadiazole derivatives (compounds 1 to 10) were prepared by nucleophilic substitution reaction between 2,5-dimercapto-1,3,4-thiadiazole and chloroheterocyclic compounds in methanol and in the presence of potassium carbonate (compounds 1 to 5 and 8) or metallic sodium (compounds 6, 7, 9 and 10) at room temperature. The cytotoxic activity was determined by green fluorescent protein (GFP)-based assay and anti-candida activity was determined by resazurin microplate assay (REMA). Compounds 1 to 4, 8 and 9 showed in vitro cytotoxic activities against Vero cells (African green monkey kidney). Compounds 4 and 10 exhibited anti-candida activities against Candida albicans (ATCC 90028) with IC50 values of 1.94 and 19.10 mu g/ml, respectively. Docking studies on the catalytic site of cytochrome P450 14 alpha-demethylase were used to identify the chemical structures in the molecule responsible for cytotoxic and anti-candida activities of the synthesized compounds.
引用
收藏
页码:477 / 485
页数:9
相关论文
共 33 条
[1]   Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2thione derivatives with carbonic anhydrase inhibitory activity [J].
Abdel-Hamid, Mohammed K. ;
Abdel-Hafez, Atef A. ;
El-Koussi, Nawal A. ;
Mahfouz, Nadia M. ;
Innocenti, Alessio ;
Supuran, Claudlu T. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (22) :6975-6984
[2]   Current and future antifungal therapy: new targets for antifungal therapy [J].
Andriole, VT .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 16 (03) :317-321
[3]   Itraconazole cyclodextrin solution: The role of in vitro susceptibility testing in predicting successful treatment of HIV-related fluconazole-resistant and fluconazole-susceptible oral candidosis [J].
Cartledge, JD ;
Midgley, J ;
Gazzard, BG .
AIDS, 1997, 11 (02) :163-168
[4]   Synthesis and antitrypanosomal profile of new functionalized 1,3,4-thiadiazole-2-arylhydrazone derivatives, designed as non-mutagenic megazol analogues [J].
Carvalho, SA ;
da Silva, EF ;
Santa-Rita, RM ;
de Castro, SL ;
Fraga, CAM .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (24) :5967-5970
[5]   Present situation in the treatment of invasive fungal infection [J].
de Pauw, Ben E. ;
Picazo, Juan J. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 :S167-S171
[6]   Synthesis of some new 1,3,4-thiadiazol-2-ylmethyl-1,2,4-triazole derivatives and investigation of their antimicrobial activities [J].
Demirbas, Ahmet ;
Sahin, Deniz ;
Demirbas, Neslihan ;
Karaoglu, Senguel Alpay .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (07) :2896-2903
[7]   Introduction to antifungal drugs [J].
Dismukes, WE .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (04) :653-657
[8]  
Dupont BF, 1996, J MYCOL MED, V6, P12
[9]   Synthesis and in vitro leishmanicidal activity of 2-(5-nitro-2-furyl) and 2-(5-nitro-2-thienyl)-5-substituted-1,3,4-thiadiazoles [J].
Foroumadi, A ;
Pournourmohammadi, S ;
Soltani, F ;
Asgharian-Rezaee, M ;
Dabiri, S ;
Kharazmi, A ;
Shafiee, A .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (08) :1983-1985
[10]  
Hunt L, 1999, BIOTECHNOL BIOENG, V65, P201, DOI 10.1002/(SICI)1097-0290(19991020)65:2<201::AID-BIT10>3.0.CO